Acura Pharmaceuticals, Inc. (ACUR)

Market Cap	1.32M
Revenue (ttm)	1.56M
Net Income (ttm)	-879.00K
Shares Out	66.50M
EPS (ttm)	-0.02
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,000
Average Volume	348
Open	0.0018
Previous Close	0.0198
Day's Range	0.0018 - 0.0198
52-Week Range	0.0002 - 0.7532
Beta	51.33
RSI	86.62
Earnings Date	Mar 31, 2025

About Acura Pharmaceuticals

Acura Pharmaceuticals, Inc., an innovative drug delivery company, engages in the research, development, and commercialization of technologies and products to address safe use of medications in the United States. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed products, which are pseudoephedrine and acetaminophen tablets that are used as nasal decongestants in various non-prescription and prescription cold, sinus, and allergy products. Acura Pharmaceuticals, ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1935
• Employees: 9
• Stock Exchange: OTCMKTS
• Ticker Symbol: ACUR

Financial Performance

In 2021, Acura Pharmaceuticals's revenue was $1.56 million, a decrease of -56.22% compared to the previous year's $3.57 million. Losses were -$879,000, -27.24% less than in 2020.